![]() Profectus BioSciences Profectus BioSciences is a company that provides vaccines for infectious diseases and cancer immunotherapy. | ![]() Ribon Therapeutics Ribon Therapeutics discovers and develops novel small molecule therapeutics for major unmet medical needs. | ![]() Peptomyc Peptomyc is a company focused on the development of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. | ![]() Zenith Epigenetics Zenith Epigenetics is a biotechnology company developing bromodomain (BET) inhibitors for the treatment of cancer and other disorders. | ||
Founding Date | Founding Date 2005 | Founding Date 2015 | Founding Date 2014 | Founding Date 2009 | Founding Date 2013 |
Type | Type Subsidiary | Type Private | Type Private | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations HQ Baltimore, US Pearl River, US | Locations Cambridge, US HQ | Locations Barcelona, ES HQ | Locations Lund, SE HQ Lund, SE Lund, SE | Locations San Francisco, US HQ Calgary, CA |
Employees | Employees 13 | Employees 614% decrease | Employees 20 | Employees 15 | Employees 118% decrease |
Funding | |||||
Total funding raised | Total funding raised $ 34.2m | Total funding raised $ 65m | Total funding raised N/A | Total funding raised $ 934.5k | Total funding raised $ 16.6m |

Ribon Therapeutics discovers and develops novel small molecule therapeutics for major unmet medical needs.
View company
Peptomyc is a company focused on the development of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment.
View companyXintela is a biomedical company working in the fields of regenerative medicine and cancer.
View company
Zenith Epigenetics is a biotechnology company developing bromodomain (BET) inhibitors for the treatment of cancer and other disorders.
View company